Ziv-aflibercept (A) combined to FOLFIRI as first line treatment for metastatic colorectal cancer (mCRC): Interim safety and efficacy results of the phase II PULSAR trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreZiv-aflibercept (A) combined to FOLFIRI as first line treatment for metastatic colorectal cancer (mCRC): Interim safety and efficacy results of the phase II PULSAR trial.
Type de publicationJournal Article
Year of Publication2017
AuteursAdenis A, Ghiringhelli F, Raoul JLuc, Tresch E, Thirot-Bidault A, Vincent J, Hajbi FEl, Hebbar M, Bouchahda M, Jarraya H, Feutray S, Amela E, Laestadius F, Le Deley M-C, Taieb S, Soncin F, Dochy E, Delaine SClisant, Penel N, Lassau N
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume35
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2017.35.4_suppl.737